Argenx (ARGX) is a global immunology company dedicated to enhancing the lives of individuals suffering from severe autoimmune diseases. With a focus on antibody innovation, Argenx brings together pioneering scientists and antibody engineers to expedite the discovery of groundbreaking treatments. Their commitment to research and development is evident in their recent success with an antibody drug that has shown significant promise in slowing the progression of a nerve disorder that affects muscle strength. Through their dedication to improving patient outcomes, Argenx is making a significant impact in the field of immunology.

Argenx $ARGX antibody drug significantly slows progression of nerve disorder that robs patients of muscle strength ...

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases.

Argenx ARGX

Find contacts at this company